DVHGF
Price
$0.13
Change
-$0.01 (-7.14%)
Updated
Dec 18 closing price
Capitalization
19.64M
RNAZ
Price
$3.35
Change
-$0.00 (-0.00%)
Updated
Jan 17 closing price
Capitalization
2.33M
Ad is loading...

DVHGF vs RNAZ

Header iconDVHGF vs RNAZ Comparison
Open Charts DVHGF vs RNAZBanner chart's image
Devonian Health Group
Price$0.13
Change-$0.01 (-7.14%)
Volume$4.5K
Capitalization19.64M
TransCode Therapeutics
Price$3.35
Change-$0.00 (-0.00%)
Volume$31.77K
Capitalization2.33M
DVHGF vs RNAZ Comparison Chart
Loading...
RNAZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DVHGF vs. RNAZ commentary
Jan 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DVHGF is a Hold and RNAZ is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 18, 2025
Stock price -- (DVHGF: $0.13 vs. RNAZ: $3.35)
Brand notoriety: DVHGF and RNAZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DVHGF: 147% vs. RNAZ: 40%
Market capitalization -- DVHGF: $19.64M vs. RNAZ: $2.33M
DVHGF [@Biotechnology] is valued at $19.64M. RNAZ’s [@Biotechnology] market capitalization is $2.33M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DVHGF’s FA Score shows that 1 FA rating(s) are green whileRNAZ’s FA Score has 1 green FA rating(s).

  • DVHGF’s FA Score: 1 green, 4 red.
  • RNAZ’s FA Score: 1 green, 4 red.
According to our system of comparison, DVHGF is a better buy in the long-term than RNAZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RNAZ’s TA Score shows that 3 TA indicator(s) are bullish.

  • RNAZ’s TA Score: 3 bullish, 2 bearish.

Price Growth

DVHGF (@Biotechnology) experienced а 0.00% price change this week, while RNAZ (@Biotechnology) price change was +2.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.65%, and the average quarterly price growth was -1.89%.

Reported Earning Dates

RNAZ is expected to report earnings on May 23, 2023.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DVHGF($19.6M) has a higher market cap than RNAZ($2.33M). DVHGF YTD gains are higher at: 0.000 vs. RNAZ (-0.593). DVHGF has higher annual earnings (EBITDA): 140K vs. RNAZ (-14.33M). DVHGF has more cash in the bank: 12.5M vs. RNAZ (1.88M). RNAZ has less debt than DVHGF: RNAZ (152K) vs DVHGF (2.27M). DVHGF has higher revenues than RNAZ: DVHGF (22.4M) vs RNAZ (0).
DVHGFRNAZDVHGF / RNAZ
Capitalization19.6M2.33M840%
EBITDA140K-14.33M-1%
Gain YTD0.000-0.593-
P/E RatioN/A0.00-
Revenue22.4M0-
Total Cash12.5M1.88M666%
Total Debt2.27M152K1,494%
TECHNICAL ANALYSIS
Technical Analysis
RNAZ
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bullish Trend 5 days ago
85%
Momentum
ODDS (%)
N/A
MACD
ODDS (%)
Bullish Trend 5 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
90%
Advances
ODDS (%)
Bullish Trend 16 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
N/A
Aroon
ODDS (%)
Bearish Trend 5 days ago
90%
View a ticker or compare two or three
Ad is loading...
RNAZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X104462.0400004705.133000
+4.72%
Bitcoin cryptocurrency
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
GME27.51-0.21
-0.76%
GameStop Corp

DVHGF and

Correlation & Price change

A.I.dvisor indicates that over the last year, DVHGF has been loosely correlated with KMSTF. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if DVHGF jumps, then KMSTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DVHGF
1D Price
Change %
DVHGF100%
N/A
KMSTF - DVHGF
53%
Loosely correlated
N/A
LIPO - DVHGF
44%
Loosely correlated
-2.40%
WINT - DVHGF
38%
Loosely correlated
-3.44%
CSPHF - DVHGF
38%
Loosely correlated
N/A
AZTR - DVHGF
29%
Poorly correlated
-8.18%
More

RNAZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, RNAZ has been loosely correlated with NGNE. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RNAZ jumps, then NGNE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNAZ
1D Price
Change %
RNAZ100%
N/A
NGNE - RNAZ
48%
Loosely correlated
-5.84%
MGNX - RNAZ
35%
Loosely correlated
-0.99%
BPTSY - RNAZ
33%
Poorly correlated
N/A
DVHGF - RNAZ
25%
Poorly correlated
N/A
JAGX - RNAZ
25%
Poorly correlated
-1.69%
More